Ctxr stock forecast.

Nov 30, 2023

Ctxr stock forecast. Things To Know About Ctxr stock forecast.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Apr 17, 2023 · The put/call ratio of CTXR is 0.03, indicating a bullish outlook. Analyst Price Forecast Suggests 314.64% Upside As of April 7, 2023, the average one-year price target for Citius Pharmaceuticals ... Predictions of CTXR stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks.The Citius Pharmaceuticals stock forecast for tomorrow is $ 0.771250, which would represent a 0.28% gain compared to the current price. In the next week, the price of CTXR is expected to decrease by -1.51% and hit $ 0.757470. As far as the long-term Citius Pharmaceuticals stock forecast is ...

Oct 15, 2020 · The Citius Pharmaceuticals stock forecast is 1.4743344248155 USD for 2024 November 22, Friday; and 4.601 USD for 2028 November 22, Wednesday with technical analysis. Citius Pharmaceuticals (CTXR) stock price prediction is 1.4743344248155 USD. Detailed statistics for Citius Pharmaceuticals, Inc. (CTXR) stock, including valuation metrics, financial numbers, share information and more. Stock Price Statistics The stock price has decreased by -33.62% in the last 52 weeks. The beta is …Citius Pharmaceuticals NasdaqCM:CTXR Stock Report Earnings vs Savings Rate: CTXR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

View real-time CTXR stock price and news, along with industry-best analysis. Citius Pharmaceuticals Inc CTXR Stock Quote - Morningstar See the latest Citius Pharmaceuticals Inc stock price (NASDAQ: CTXR ), related news, valuation, dividends and more to help you make your investing decisions.Forecast Price target 8.00 0.00 0.00% The 1 analyst offering 1 year price forecasts for CTXR have a max estimate of — and a min estimate of —. Analyst rating Based on 1 …

According to some industry analysts covering Citius Pharmaceuticals, breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$56m in ...Corporate Overview. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products.The average 89bio stock price prediction forecasts a potential upside of 333.25% from the current ETNB share price of $8.04. What is ETNB's forecast return on equity ...Palantir Technologies Inc. (NYSE:PLTR) posted its quarterly earnings results on Thursday, November, 2nd. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. The company earned $558.16 million during the quarter, compared to the consensus estimate of $554.61 million.

Citius Pharmaceuticals didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. Nonetheless, we can still examine its cash burn ...

CTXR Stock Analysis Overview What this means: InvestorsObserver gives Citius Pharmaceuticals Inc (CTXR) an overall rank of 38, which is below average. Citius Pharmaceuticals Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

The average price target for Citius Pharmaceuticals is $4.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00 ,the lowest forecast is $4.00. The average price target represents 415.40% Increase from the current price of $0.776. Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 2.65, with a high estimate of 12.35 and a low estimate of 1.25. The median ... The average Southwest Airlines Co stock price prediction forecasts a potential upside of 21.83% from the current LUV share price of $26.69. What is LUV's forecast return on equity (ROE) for 2023-2026? (NYSE: LUV) forecast ROE is N/A, which is considered .View the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ.Citius Pharmaceuticals Inc. analyst estimates, including CTXR earnings per share estimates and analyst recommendations.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.

The yield on the 10-Year Treasury moved up sharply as the January BLS Jobs report showed 517,000 jobs were created in the first month of 2023 and the unemployment rate fell to 3. Get the latest ...Dec 1, 2023 · Corporate Overview. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products. Stock Price Market cap Dividend Forecast Employees Revenue Stories Citius Pharmaceuticals, Inc. (CTXR) Stock Price Forecast Citius Pharmaceuticals, Inc. (CTXR) average Stock Price Forecast target 2023 is $-0.40 with a high forecast of $-1.11 and a …Complete Citius Pharmaceuticals Inc. stock information by Barron's. View real-time CTXR stock price and news, along with industry-best analysis. Citius Pharmaceuticals Inc. analyst estimates, including CTXR earnings per share estimates and analyst recommendations.Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Sep 8, 2023 · CTXR Stock Forecast: Analysts Predict 354.60% Increase in Value over Next 12 Months. On September 8, 2023, Citius Pharmaceuticals Inc (CTXR) had a median target price of $4.00, according to three analysts offering 12-month price forecasts. The high estimate for the stock was $8.00, while the low estimate stood at $4.00. When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

View the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ.Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.Based on analysts offering 12 month price targets for CTXR in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...May 5, 2023 · CTXR stock closed at $1.25 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CTXR has a strong overall score of 83Apr 24, 2023 · The company’s next reporting date is on May 11, 2023, with an EPS forecast of -$0.04. Its annual revenue for the last year was $0.00, and it had an annual profit of -$33.6M. The net profit margin for CTXR is not available. Citius Pharmaceuticals Inc (CTXR) Targets $6.00 Median Price Forecast, +313.79% Increase – Buy CTXR Stock The Citius Pharmaceuticals stock forecast for tomorrow is $ 0.771250, which would represent a 0.28% gain compared to the current price. In the next week, the price of CTXR is expected to decrease by -1.51% and hit $ 0.757470. As far as the long-term Citius Pharmaceuticals stock forecast is ...View real-time CTXR stock price and news, along with industry-best analysis. Citius Pharmaceuticals, Inc. Common Stock ( CTXR ) - Nasdaq Key Data ; Share Volume, 898,308 ; Average Volume, 957,784 ; Previous Close, $1.13 ; …Financials. Next reporting date. February 23, 2024. EPS forecast (this quarter) $0.60. Annual revenue (last year) $9.5B. Annual profit (last year)

Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

CTR support price is $31.78 and resistance is $33.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTR stock will trade within this expected range on the day. View a ...

Citius Pharmaceuticals, Inc. (CTXR) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.7680 +0.0027 (+0.35%) At …The put/call ratio of CTXR is 0.03, indicating a bullish outlook. Analyst Price Forecast Suggests 314.64% Upside As of April 7, 2023, the average one-year price target for Citius Pharmaceuticals ...The average price target for Citius Pharmaceuticals is $4.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00 ,the lowest forecast is $4.00. The average price target represents 415.40% Increase from the current price of $0.776.Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.Track Citius Pharmaceuticals Inc (CTXR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsView the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ. The average stock forecast for Citius Pharmaceuticals Inc (CTXR) is 5.44 USD. This price target corresponds to an upside of 603.84%. The range of stock forecasts for CTXR is 4.04 - 8.40 USD. Based on the ratings of 9, the consensus recommendation for CTXR isThe put/call ratio of CTXR is 0.03, indicating a bullish outlook. Analyst Price Forecast Suggests 314.64% Upside As of April 7, 2023, the average one-year price target for Citius Pharmaceuticals ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for CEL-SCI Corp have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

ISIN. US17322U2078. Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.Citius Pharmaceuticals Stock Forecast. Is Citius Pharmaceuticals Stock Undervalued? The current Citius Pharmaceuticals [ CTXR] share price is $0.78. The Score for CTXR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CTXR is currently trading in the 50-60% percentile range relative to its historical ...Find the latest analyst research for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Instagram:https://instagram. compare fidelity fundscollecting penniesamerican balanced fund class acollectors insurance services Stock Price Market cap Dividend Forecast Employees Revenue Stories Citius Pharmaceuticals, Inc. (CTXR) Stock Price Forecast Citius Pharmaceuticals, Inc. (CTXR) average Stock Price Forecast target 2023 is $-0.40 with a high forecast of $-1.11 and a … average employer 401k matchforeign exchange market training Forty percent of the $1.5 billion market is $600 million. The average price-to-sales ratio (P/S) for a biotech stock is 8.09. That means when we multiply the yearly revenue of $600 million by the ...Citius Pharmaceuticals (CTXR) is a late-stage pharmaceutical company developing critical care products for oncology, anti-infectives, prescription and stem cell therapy. The company has a consensus rating of Buy and a forecasted upside of 433.3% from its current price of $0.75. See the latest news, analysis and earnings reports for CTXR stock. grendier ctxr stock forecast zacks ctxr price target reddit ctxr stock split citius pharmaceuticals why is ctxr stock down ctxr stock forecast 2025 ctxr yahoo finance Popular Search Web Page Citius Pharmaceuticals ($ CTXR ) – THREE products with upcoming ...The current average CTXR price target, as estimated by these analysts, is $0.00. The predictions for the future CTXR stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CTXR.